フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that the Company has completed an independent market survey...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that the Company has received its FDA consulting firm’s...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that it continues efforts to resolve the trading issue with...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that it has retained a new FDA consulting company to assist in...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that it has retained legal counsel to resolve the trading...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that it has provided information to Depository Trust...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today announced the completion of the updating and launch of its website...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) has learned that the U.S. Securities and Exchange Commission has filed an...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today reported expectations of its FDA consultant’s report by the middle of...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today reported the regulatory strategy for its First Warning System™ is well...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today reported on the results of the FDA submission of its First Warning...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today announced that it has completed the updating of the Company's...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today reported that management has recently returned from Singapore where...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM D OMB APPROVAL OMB Number: 3235-0076 Expires: June 30, 2012...
Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today reported on the status of the pending FDA submission of its First...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約